Sort   by:  
 Page size 
UnknownPhase I trial of bortezomib (PS-341; NSC 681239) and "nonhybrid" (bolus) infusion schedule of alvocidib (flavopiridol; NSC 649890) in patients with recurrent or refractory indolent B-cell neoplasms.
Not available
S-EPMC4233160 | biostudies-literature
UnknownResidual lung abnormality following COVID-19 hospitalisation is characterised by biomarkers of epithelial injury.
Not available
S-EPMC12860639 | biostudies-literature
UnknownCOVID-19 due to the B.1.617.2 (Delta) variant compared to B.1.1.7 (Alpha) variant of SARS-CoV-2: a prospective observational cohort study.
Not available
S-EPMC9240087 | biostudies-literature
UnknownDecline in estimated glomerular filtration rate and subsequent risk of end-stage renal disease and mortality.
Not available
S-EPMC4172342 | biostudies-literature
UnknownPast Decline Versus Current eGFR and Subsequent ESRD Risk.
Not available
S-EPMC4978053 | biostudies-literature
UnknownPast Decline Versus Current eGFR and Subsequent Mortality Risk.
Not available
S-EPMC4978054 | biostudies-literature
UnknownAge and association of kidney measures with mortality and end-stage renal disease.
Not available
S-EPMC3936348 | biostudies-literature
UnknownAssociations of estimated glomerular filtration rate and albuminuria with mortality and renal failure by sex: a meta-analysis.
Not available
S-EPMC3558410 | biostudies-literature
UnknownMeasurement of circulating viral antigens post-SARS-CoV-2 infection in a multicohort study.
Not available
S-EPMC11578795 | biostudies-literature
UnknownOlfactory Dysfunction After SARS-CoV-2 Infection in the RECOVER Adult Cohort.
Not available
S-EPMC12464792 | biostudies-literature
Sort   by:  
 Page size